Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 32.43
0.123 %
$ 1.82 B
Market Cap
24.57
P/E
SUPN - REVENUE
Revenue SUPN - Supernus Pharmaceuticals, Inc.
662 M
LAST VALUE
-0.41%
2 YEAR CAGR
11.00%
5 YEAR CAGR
18.42%
10 YEAR CAGR